Chen Yushi, Sun Ye, Zhao Qiuyu, Liu Chunying, Wang Chun
College of Integrated Chinese and Western Medical, Liaoning University of Traditional Chinese Medicine, Shenyang 110847, Liaoning, China.
Basic Medical College, Shenyang Medical College, Shenyang 110034, Liaoning, China.
Cancer Drug Resist. 2021 Dec 10;4(4):1047-1060. doi: 10.20517/cdr.2021.94. eCollection 2021.
Chemoresistance is the biggest obstacle in cancer treatment. Our previous study demonstrated that Shenmai injection (SMI), a Chinese herbal medicine, enhanced the antitumor effect of cisplatin via glucose metabolism reprogramming. This study aimed to further determine whether the SMI sensitizes the non-small cell lung cancer (NSCLC) cells to cisplatin through regulation mitochondrial dynamics. The Kaplan-Meier Plotter database was used to investigate the relationship between mRNA expression of mitofusin-2 (Mfn2) and the survival analysis of NSCLC patients. The protein expression of Mfn2 in a lung adenocarcinoma tissue chip was detected by immunohistochemistry staining. The expression of Mfn2 and ATAD3A were compared between cisplatin-sensitive A549 and cisplatin-resistant A549/DDP cells. Additionally, A549/DDP cells were co-treated with cisplatin and SMI to detect mitochondrial morphology by fluorescent staining, apoptosis-related protein expression with Western blotting, and mitochondrial membrane potential (ΔΨm) with flow cytometry analysis. The mean survival time of the Mfn2 group was significantly lower than that of the Mfn2 group by Kaplan-Meier Plotter database analysis, and the Mfn2 protein expression level was lower in cancer tissues than in adjacent tissues. The combination of SMI and cisplatin induced dynamic changes in A549/DDP cells, with increased mitochondrial fusion followed by upregulation of Mfn2 and downregulation of ATAD3A and reduced mitochondrial mass and ΔΨm. Moreover, SMI significantly enhanced cisplatin-induced A549/DDP apoptosis, upregulated Bax and the active subunit of caspase-3, and downregulated Bcl-2 expression, as shown via Hoechst staining and flow cytometry analysis. Our findings suggest SMI enhances cisplatin-induced apoptosis through regulation of Mfn2-dependent mitochondrial dynamics in cisplatin-resistant lung adenocarcinoma cells.
化疗耐药是癌症治疗中的最大障碍。我们之前的研究表明,中药参麦注射液(SMI)通过葡萄糖代谢重编程增强了顺铂的抗肿瘤作用。本研究旨在进一步确定SMI是否通过调节线粒体动力学使非小细胞肺癌(NSCLC)细胞对顺铂敏感。使用Kaplan-Meier Plotter数据库研究线粒体融合蛋白2(Mfn2)的mRNA表达与NSCLC患者生存分析之间的关系。通过免疫组织化学染色检测肺腺癌组织芯片中Mfn2的蛋白表达。比较顺铂敏感的A549细胞和顺铂耐药的A549/DDP细胞中Mfn2和ATAD3A的表达。此外,将A549/DDP细胞与顺铂和SMI共同处理,通过荧光染色检测线粒体形态,通过蛋白质印迹法检测凋亡相关蛋白表达,通过流式细胞术分析检测线粒体膜电位(ΔΨm)。通过Kaplan-Meier Plotter数据库分析,Mfn2组的平均生存时间显著低于Mfn2组,癌组织中Mfn2蛋白表达水平低于相邻组织。SMI与顺铂联合使用诱导A549/DDP细胞发生动态变化,线粒体融合增加,随后Mfn2上调,ATAD3A下调,线粒体质量和ΔΨm降低。此外,如通过Hoechst染色和流式细胞术分析所示,SMI显著增强顺铂诱导的A549/DDP细胞凋亡,上调Bax和caspase-3的活性亚基,并下调Bcl-2表达。我们的研究结果表明,SMI通过调节顺铂耐药肺腺癌细胞中依赖Mfn2的线粒体动力学增强顺铂诱导的凋亡。